The review article titled“Sexual dysfunction after Rezum therapy for benign prostatic hyperplasia: A scoping review for the current insights and findings”, was published on December 10, 2024 in ...
Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Hosted on MSN
Docs perform Rezum on two BPH patients
Rezum therapy is a US FDA-approved procedure that uses the natural energy stored in water vapour to shrink excess prostate tissue and relieve urinary symptoms. One of the patients, Nakul Mistri, 84, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback